* Information available to verified or subscribed users. The first stage in this process is to Register - please
click here to Register.
If you have already Registered, please click here to login.
|
| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 |
| Phrase | Consultant | Town | Special Interests |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, thyroid cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lymphoma, head and neck cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, skin cancer, urological cancer, central nervous system cancers, thyroid cancer, radiotherapy, chemotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, urological cancer, prostate brachytherapy, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer - Intensity Modulated Radiotherapy - IMRT, head and neck cancer -proton beam radiotherapy, olfactory neuroblastoma and sionnasal tumours are a special interest, stereotactic ablative body radiotherapy - SABR |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal oncology, lymphoma, lung cancer, haematological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, chemotherapy, immunotherapy, metastatic cancer, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, stereotactic radiotherapy for lung tumours, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, gynaecological cancer, prostate cancer, lung cancer, lymphoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, skin cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer, lung cancer, haematological malignancy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, lung cancer, prostate brachytherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, paediatric radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, mesothelioma, upper gastrointestinal cancer, cancer of unknown primary, thymic tumours, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, medical oncology, breast cancer, urological cancer, sarcoma and palliative care |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, central nervous system cancers, upper gastrointestinal cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate brachytherapy, urological cancers, stereotactic ablative radiotherapy - SABR |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology and gamma knife radiosurgery, melanoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological malignancies, nonmelanoma skin cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, gastrointestinal cancers, pancreatic cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, skin cancer, cancer education, melanoma, geriatric oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, head and neck cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, gynaecological cancer, skin cancer, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, soft tissue tumours in adults and children - radiotherapy only, gynaecological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, gastrointestinal cancer, lung cancer, skin cancer, thyroid cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lymphoma, colorectal cancer, soft tissue sarcoma, gastrointestinal oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancers, lymphoma, urological cancers, colorectal cancers, prostate cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, mesothelioma, prostate cancer, bladder cancer, kidney cancers, upper gastrointestinal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lymphoma, urological cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological tumours, gastrointestinal cancer, bone tumours and sarcoma, breast cancer, lung cancer, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, hepatobiliary oncology, thyroid cancer, upper gastrointestinal oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, thoracic and breast cancers, radiotherapy and chemotherapy, mesothelioma thymic tumours |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, bone tumours, carcinoma, brain tumours, paediatric tumours, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, skin cancer, sarcoma, melanoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, breast cancer, upper and lower gastrointestinal cancer, systemic therapy Iodine 131 MIBG for neuroendocrine tumours, gastrointestinal chemoradiotherapy, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, cervical cancer, endometrial cancer, ovarian cancer, vulval cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, breast oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper and lower gastrointestinal cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, brain tumours |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, urological cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate brachytherapy, urological oncology, radiotherapy for lymphoma, nonmelanomatous skin cancers, haematological oncology |
| Page No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 |
|
|
|
|
